Vor Biopharma Inc. (VOR) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Vor Biopharma Inc. (VOR) closed at USD 18.75 on 2026-10-14, a change of -30.4 % over the past year, with a market capitalization of USD 1.05B.

Vor Biopharma Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Vor Biopharma Inc. key figures

Previous close

USD 18.75 (2026-10-14)

1-year change

-30.4 %

Market cap

USD 1.05B

Enterprise value

USD 680.95M

P/E ratio (trailing)

0.11

P/E ratio (forward)

-5.09

EPS (trailing)

181.14

EPS (forward)

-3.80

PEG ratio

n/a

Price to book

-5.26

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.11

Employees

76

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Vor Biopharma Inc.

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Vor Biopharma Inc. and compare it with other stocks.